Molecular classification of membranous nephropathy

Area of Science:

• Nephrology
• Immunology
• Pathogenesis of Kidney Diseases

Background:

• Membranous nephropathy pathogenesis is increasingly understood through identifying antibodies targeting podocyte antigens.
• Circulating anti-phospholipase A2 receptor (PLA2R) and anti-thrombospondin domain 7A (THSD7A) antibodies are key in diagnosis and understanding podocyte biology.

Purpose of the Study:

• To review advancements in understanding membranous nephropathy pathogenesis via antibody identification.
• To discuss the diagnostic and prognostic implications of anti-PLA2R and anti-THSD7A antibodies.

Main Methods:

• Review of current literature on membranous nephropathy, podocyte antigens, and associated antibodies.
• Analysis of experimental data regarding the roles of THSD7A and PLA2R in disease mechanisms.
• Examination of clinical guidelines and their recommendations for antibody monitoring.

Main Results:

• Anti-PLA2R and anti-THSD7A antibodies are strongly linked to podocyte alterations and membranous nephropathy diagnosis.
• While THSD7A immunization involves extra-renal mechanisms and its role in podocyte attachment is clear, the anti-PLA2R pathway is less understood.
• Epitope spreading of anti-PLA2R antibodies may offer more specific markers for molecular classification, unlike THSD7A which has identified epitopes but no evidence of spreading.

Conclusions:

• The 2019 KDIGO guidelines recognize anti-PLA2R antibodies as a crucial risk factor for monitoring kidney function in membranous nephropathy.
• Anti-THSD7A antibodies are associated with membranous nephropathy, and screening for malignancy is recommended in these cases.
• Further research into anti-PLA2R epitope spreading could refine molecular classification and patient management strategies for membranous nephropathy.